Gilead Sciences Inc
NASDAQ:GILD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gilead Sciences Inc
NASDAQ:GILD
|
US |
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
|
AeroVironment Inc
NASDAQ:AVAV
|
US |
|
SBC Exports Ltd
NSE:SBC
|
IN |
|
M
|
Mobotix AG
XBER:MBQ
|
DE |
|
H
|
Hartford Financial Services Group Inc
XBER:HFF
|
US |
Wall St Price Targets
GILD Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GILD is 161.68 USD with a low forecast of 123.22 USD and a high forecast of 189 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GILD's stock price target?
Price Target
161.68
USD
According to Wall Street analysts, the average 1-year price target for GILD is 161.68 USD with a low forecast of 123.22 USD and a high forecast of 189 USD.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
